Posted on 2/12/21
Novavax Gets the Job Done With its COVID Vaccine
In this video from Motley Fool Liverecorded on Feb. 1, Fool.com contributors Brian Orelli and Keith Speights discussed phase 3 clinical trial data on Novavax's (NASDAQ:NVAX) . . .
Posted on 2/12/21
Forget Moderna! This Is a More Lucrative Coronavirus Stock
In the first 10 years of Moderna's (NASDAQ:MRNA) existence, the pharmaceutical and biotechnology company didn't launch a single product onto the market. That changed last December . . .
Posted on 2/12/21
Longeveron Prices of an Upsized $26.6 Million IPO and Nasdaq Listing
MIAMI, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced . . .
Posted on 2/12/21
Codiak Prices of $57.8 Million Public Offering of Common Stock
CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as . . .
Posted on 2/12/21
NexImmune Prices of Upsized IPO
GAITHERSBURG, Md., Feb. 11, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc., a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s own . . .
Posted on 2/12/21
Decibel Therapeutics Prices of IPO
BOSTON, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve . . .
Posted on 2/12/21
Applied Therapeutics Prices Public Offering of 3M Shares of Common Stock
NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated . . .
Posted on 2/12/21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
CHARLOTTESVILLE, Va., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN), an innovative clinical stage biopharmaceutical company developing novel therapies to enhance the diffusion . . .
Posted on 2/12/21
Infinity Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (Nasdaq: INFI), a clinical-stage biotechnology company developing eganelisib, an oral, immuno-oncology macrophage reprogramming therapeutic candidate, which is designed to address a . . .
Posted on 2/12/21
Maryland’s Average Positive Test Rate Continues to Decline
The average percentage of Maryland’s coronavirus tests in the past seven-day period that have come back positive continues to decline, reaching 5.08% on Thursday.The seven-day average . . .
Posted on 2/11/21
DLA Piper Advises EQ Health Acquisition Corp. in its Upsized $220 Million IPO
DLA Piper represented EQ Health Acquisition Corp. in its recent upsized initial public offering of 21,999,960 units at a price of $10 per unit. Each unit . . .
Posted on 2/11/21
Columbia Care Announces C$25 Million Bought Private Placement Offering
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. . . .
Posted on 2/11/21
Cyteir Therapeutics Secures $80 Million in Series C
Cyteir Therapeutics, a leader in the discovery and development of next-generation synthetic lethal therapies for cancer, today announced the close of an oversubscribed $80 million Series . . .
Posted on 2/11/21
Pulmatrix Announces $40 Million Registered Direct Offering
Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today . . .
Posted on 2/11/21
TherapeuticsMD Prices of $110 Million Public Offering of Common Stock
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ:TXMD) today announced the pricing of its underwritten public offering of approximately 59.5 million shares of its common stock for gross . . .
Posted on 2/11/21
Signify Health Prices of IPO
DALLAS & NORWALK, Conn.--(BUSINESS WIRE)--Signify Health, Inc. a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, today announced the pricing of . . .
Posted on 2/11/21
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Period Activity
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and full year ended . . .
Posted on 2/11/21
BIONIK Laboratories Reports Fiscal 2021 Q3 Financial Results
TORONTO & BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB:BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from . . .
Posted on 2/11/21
AlloVir Reports Full Year 2020 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, today provided a corporate update and reported full-year 2020 financial results for the period ended . . .
Posted on 2/11/21
Genocea Provides Fourth Quarter 2020 Corporate Update
CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today provided a business update for . . .
Posted on 2/11/21
VYNE Therapeutics Announces Reverse Stock Split
BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) today announced that its Board of Directors has approved a reverse stock split . . .
Posted on 2/11/21
Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business Outlook
NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp.(Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and . . .
Posted on 2/11/21
Acorda Therapeutics Sale of Manufacturing Operations to Catalent
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has completed the sale of its manufacturing operations in Chelsea, Massachusetts to Catalent. Under the . . .
Posted on 2/11/21
Could Novavax Win U.S. Authorization for Its COVID Vaccine Sooner Than Expected?
Novavax(NASDAQ:NVAX) recently reported very good results from a late-stage study conducted in the United Kingdom of its COVID-19 vaccine candidate. The company's CEO wants the U.S. . . .
Posted on 2/11/21
What Are Pfizer's Prospects in 2021 and Beyond?
Pfizer(NYSE:PFE) missed Wall Street's earnings estimate when the big drugmaker reported its fourth-quarter results recently. However, those results didn't account for the tremendous growth that the . . .
